4Franz HM. Reinhard K. Left ventricular hypertrophy, a pressure independent cardiovascular risk factor, j cardiovasc pharmacol, 1993,22(suppl 1):713.
5Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventrleular hypertrophy comparison to necropsy findings. Am J Cardiol, 1986,57:450-454.
6Pahor M, Bernibei R, Sgidari A, et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension, 1991, 18:148.
7Hua L, Li C, Xia D, et al. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res, 2000,23 : 377-380.
8Kamide K, Nagano M, Nakano N, et al. Insulin resistance and cardiovascular complications in patients with essential hypertension. Am J Hyperten,1996,9:1165-1171.
9Davis BR, Furberg CD, Wright J J, et al . ALLHAT: setting the record straight[J ] .Ann Intern Med, 2004, 141(1):39.
10Epstein M, Compese WM. Evolving role of calcium antagonists in the management of hypertension[J ] .Med Clin NAm, 2004, 88(1): 149.
